You just read:

Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

News provided by

Sutro Biopharma, Inc.

Oct 16, 2019, 16:35 ET